
aXichem Investor Relations Material
Latest events

Q2 2025
aXichem

Q2 2025
28 Aug, 2025

Q1 2025
22 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from aXichem
Access all reports
aXichem AB is a Swedish biotechnology company focused on developing natural analogue ingredients. Its flagship product, phenylcapsaicin, is a synthetic version of capsaicin used in various industries, including animal feed, dietary supplements, and marine applications. The company's solutions include aXivite, which is used in health supplements to support weight management and gut health, and aXiphen, a bio-repellent applied in agriculture, marine antifouling, and animal feed to promote health and prevent issues like salmonella in poultry. The company is headquartered in Malmö, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
AXIC
Country
🇸🇪 Sweden